These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8416872)

  • 1. Relative clinical influence of tumor dose versus dose per fraction on the local control and late normal-tissue morbidity after larynx radiotherapy.
    Million RR
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):149-50. PubMed ID: 8416872
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy.
    Slevin NJ; Vasanthan S; Dougal M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):23-8. PubMed ID: 8416877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epithelioma of the larynx. Considerations on radiotherapy treatments and their results].
    Dancot H; Feremans W
    J Belge Radiol; 1974; 57(4):277-91. PubMed ID: 4430665
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
    van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supervoltage radiotherapy for carcinoma of the larynx the Johns Hopkins Hospital results 1961 to 1967.
    Lott S; el-Mahdi AM; Hazra T
    Johns Hopkins Med J; 1972 Apr; 130(4):244-53. PubMed ID: 4621905
    [No Abstract]   [Full Text] [Related]  

  • 6. Review article--radiation therapy in diseases of the larynx.
    Morrison R
    Br J Radiol; 1971 Jul; 44(523):489-504. PubMed ID: 4933119
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis.
    Rudoltz MS; Benammar A; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):767-72. PubMed ID: 8344844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regarding Million's editorial on the "Relative clinical influence of tumor dose versus dose per fraction ... following larynx radiotherapy".
    Ramsay J
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):485. PubMed ID: 8407427
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiotherapy of early glottic cancer--I.
    Harwood AR; Hawkins NV; Rider WD; Bryce DP
    Int J Radiat Oncol Biol Phys; 1979 Apr; 5(4):473-6. PubMed ID: 457491
    [No Abstract]   [Full Text] [Related]  

  • 10. T4NOMO glottic cancer: an analysis of dose-time volume factors.
    Harwood AR; Beale FA; Cummings BJ; Keane TJ; Payne D; Rider WD
    Int J Radiat Oncol Biol Phys; 1981 Nov; 7(11):1507-12. PubMed ID: 7333899
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of radiation therapy in the treatment of laryngeal cancer.
    Botnick LE; Rose CM; Goldberg I; Recht A
    Otolaryngol Clin North Am; 1984 Feb; 17(1):227-35. PubMed ID: 6718020
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of oxygen and hypoxia on laryngeal cancer management.
    Henk JM
    Laryngoscope; 1975 Jul; 85(7):1134-44. PubMed ID: 807785
    [No Abstract]   [Full Text] [Related]  

  • 13. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
    Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
    Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Has the use of Co 60 in the treatment of laryngeal carcinoma enlarged its application for primary radiotherapy?].
    Tölle D; Eberhardt HJ
    HNO; 1972 Jan; 20(1):8-11. PubMed ID: 4622702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment results of supraglottic carcinoma by radiotherapy (author's transl)].
    Arisawa J; Ikeda H; Miyata Y; Masaki N; Shigematsu Y; Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980; 40(2):149-55. PubMed ID: 7375341
    [No Abstract]   [Full Text] [Related]  

  • 16. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.
    Zumsteg ZS; Riaz N; Jaffery S; Hu M; Gelblum D; Zhou Y; Mychalczak B; Zelefsky MJ; Wolden S; Rao S; Lee NY
    Oral Oncol; 2015 Jul; 51(7):716-23. PubMed ID: 25958831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Lindstrom and Fowler's "The influence of dose and time on local control of carcinoma of the larynx by radiation therapy".
    Baumann M; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1163. PubMed ID: 1555971
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy.
    Fowler JF; Chappell R
    Eur J Cancer; 1994; 30A(5):719-21. PubMed ID: 8080696
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiotherapeutic treatment of tumors of the larynx].
    Esco R; Navarrete S; Castillo A; Marin Gorriz F
    Rev Esp Oncol; 1983; 30(1):41-56. PubMed ID: 6208583
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.